Market Place
Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings. 
X
Please Wait
Applying Filters...
01 Excella GmbH & Co. K.G. (1)
02 PCAS S. A. (1)
01 Tamoxifen citrate (2)
01 France (1)
02 Luxembourg (1)
92
PharmaCompass offers a list of Tamoxifen Citrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tamoxifen Citrate manufacturer or Tamoxifen Citrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tamoxifen Citrate manufacturer or Tamoxifen Citrate supplier.
PharmaCompass also assists you with knowing the Tamoxifen Citrate API Price utilized in the formulation of products. Tamoxifen Citrate API Price is not always fixed or binding as the Tamoxifen Citrate Price is obtained through a variety of data sources. The Tamoxifen Citrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tamoxifen Citrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tamoxifen Citrate, including repackagers and relabelers. The FDA regulates Tamoxifen Citrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tamoxifen Citrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tamoxifen Citrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tamoxifen Citrate supplier is an individual or a company that provides Tamoxifen Citrate active pharmaceutical ingredient (API) or Tamoxifen Citrate finished formulations upon request. The Tamoxifen Citrate suppliers may include Tamoxifen Citrate API manufacturers, exporters, distributors and traders.
click here to find a list of Tamoxifen Citrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tamoxifen Citrate Drug Master File in Japan (Tamoxifen Citrate JDMF) empowers Tamoxifen Citrate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tamoxifen Citrate JDMF during the approval evaluation for pharmaceutical products. At the time of Tamoxifen Citrate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tamoxifen Citrate suppliers with JDMF on PharmaCompass.
